LLS: The Role of Nurses in Treating Blood Cancers

The Leukemia & Lymphoma Society (LLS) is pleased to share a webcast from our symposium held in conjunction with the Oncology Nursing Society 40th Annual Congress in Orlando, Florida on April 25, 2015. Two additional presentations expanding on topics covered during the live symposium are also included.


  • Emily Bennett, RN, BSN, Nurse Navigator, Winship Cancer Institute, Emory University
    Atlanta, GA
  • Beth Finley, RN, BSNc, OCN, Primary Nurse, Moffitt Cancer Center, Tampa, FL
  • Lynn Rich, ANP-BC, OCN, Nurse Practitioner, JP Wilmot Cancer Center, University of Rochester
    Rochester, NY


This activity has been designed to meet the educational needs of nurses and social workers at intermediate and advanced levels of practice and other healthcare professionals involved in the care of patients with hematologic cancers.

Through a presentation of case studies, best practices for patient management are shared. Important themes are highlighted throughout each case, including treatment, side effect management, and effective communication tools for educating patients on clinical trials. The 1.5 hour program includes four cases – two presented at the live symposium at ONS and two recorded after the live program by our expert panel. The 1.0 hour program includes two case studies.

At the conclusion of this program, participants should be able to:

  • Identify two newly approved therapies for the treatment of patients with blood cancer
    List two factors used to assess and establish individualized treatment plans
    Explain methods for managing two potential treatment-related side effects
    Describe communication strategies for educating patients on treatment adherence
    Identify resources for addressing treatment and survivorship challenges


  • Acute Promyelocytic Leukemia (APL)
    Chronic Lymphocytic Leukemia (CLL)
    Follicular Lymphoma
    Multiple Myeloma

Click here for additional Continuing Education information.

There is no fee for this education activity.

For more information about hematologic malignancies, contact an LLS Information Specialist at
(800) 955-4572 or infocenter@LLS.org, or visit www.LLS.org.


No comments have been posted yet.